HomeAI · summaries
Storia in 3 fonti
Cellares rebukes Bristol Myers' criticism of its cell therapy technology
Cellares cuts 100 jobs after Bristol Myers ends Breyanzi manufacturing deal; startup disputes claims its Cell Shuttle tech fell short.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Cellares, a cell therapy manufacturing specialist, to lay off 100 employees
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn.
- ·
fiercepharma.com
Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer
With its ascent seemingly unstoppable in the last few years, automated cell therapy manufacturer Cellares is facing some tough new realities. | With its ascent seemingly…
